REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $635 | -16.2% | 19,719 | -52.0% | 0.01% | -33.3% |
Q4 2022 | $758 | -99.9% | 41,076 | -44.6% | 0.02% | -44.4% |
Q2 2022 | $1,024,000 | -41.4% | 74,119 | -17.3% | 0.03% | -34.1% |
Q1 2022 | $1,747,000 | -8.8% | 89,572 | +38.6% | 0.04% | +13.9% |
Q2 2021 | $1,915,000 | +417.6% | 64,616 | +137.6% | 0.04% | +350.0% |
Q2 2016 | $370,000 | -1.6% | 27,200 | +147.3% | 0.01% | -27.3% |
Q4 2015 | $376,000 | – | 11,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |